Raymond James Financial
DERM icon

Raymond James Financial’s Journey Medical DERM Stock Holding History

Raymond James Financial’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,000
Closed -$35.9K – 5410
2025
Q2 		$35.9K Buy
+5,000
New +$34.6K ﹤0.01% 5313

Other funds holding DERM

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

Raymond James Financial's DERM Position: Q3 2025 in Review

Raymond James Financial sold out of Journey Medical (DERM) in Q3 2025, closing a stake of 5,000 shares — an estimated $35.9K sold.

Raymond James Financial first reported a position in DERM in Q2 2025 and held it in 1 quarter. The position peaked at $35.9K in Q2 2025. 68 funds tracked by Wall St. Rank hold DERM as of Q3 2025.

  • Raymond James Financial reported no remaining Journey Medical position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 5,000 Journey Medical shares in Q3 2025, an estimated $35.9K.
  • Raymond James Financial first reported a position in Journey Medical in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Journey Medical position peaked at $35.9K in Q2 2025.
  • 68 funds tracked by Wall St. Rank held Journey Medical as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.